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Shi, Marlene. Infectious diseases still 
plague much of the developing world. Rapid 
and accurate diagnosis of diseases such as 
malaria, tuberculosis, and HIV is critical for 
improved control and management allowing 
for targeted and effective treatment.  The 
Whitesides Research Group led by George 
Whitesides, the Woodford L. and Ann A. 
Flowers University Professor at Harvard, 
has developed a low-cost paper based 
diagnostic test that follows the principles of 
microfludics using paper’s inherent channels 
and natural capillary action.    
The first application that the 
Whitesides paper diagnostic test will 
perform is liver toxicity screening. The 
printing method for these diagnostic tests 
will model the newspaper press print format 
for efficient and speedy production. The 
Whitesides Group intends the test results to 
be analyzed using telemedicine. Camera 
phones will transmit images of the test to a 
lab where a doctor or a computer can make a 
diagnosis.  
The key area that has not yet been 
explicitly defined is the method of 
packaging, distribution, and portability of 
the paper diagnostic test squares. The 
proposed paper diagnostic dispenser will 
make the tests portable which will increase 
access to diagnostic tools in the developing 
world. Heath care volunteers will be able to 
carry the tests in a simple container and 
dispense test squares as needed. This device 
increases the mobility of health care workers, 
requires little to no training to use, and 
facilitates the decentralization of health care 




Problem: The need for standard diagnostics 
 
Despite successes in smallpox and 
polio eradication, age-old infectious diseases 
have yet to become obsolete. Historic 
diseases such as malaria and tuberculosis 
still plague much of the developing world. 
The World Health Organization (WHO) 
promotes global health initiatives, and 
infectious diseases have always been the top 
priority [15]. Progress in eradicating 
infectious diseases is particularly 
measureable in terms of prevention, control, 
treatment, and cure [15].   
Current studies reveal that malaria, 




contributors of mortality in developing 
countries. Over 95% of these deaths are 
caused by the lack of proper diagnosis and 
treatment, yet the standard diagnostic 
techniques listed in Fig. 2 below are costly, 
slow, and limited in sensitivity to different 
pathogens [10].  
   Given this startling statistic, there is a 
clear need to develop diagnostic devices for 
countries where access to adequate health 
care infrastructure is limited. New advanced 
medical technology is being produced such 
as lab-on-a chip devices. However common 
platforms made of glass or other forms with 
sensors are expensive and for a developing 
country – cost as well as cost effectiveness 
determine health care decisions.  
 
Case study I. Malaria  
 
    Fever, chills and vomiting are 
common symptoms at the onset of malaria, 
but when mild these symptoms do not 
clearly indicate infection [18]. Rapid and 
accurate diagnosis is critical because malaria 
can progress to severe illness after 24 hours 
of infection [18]. In 2009, malaria was the 
cause of over one million deaths worldwide 
[18]. In Africa one child dies every 45 
seconds of malaria [18].  
    In a public health study conducted in 
the tribal belt of Central India where there is 
a high prevalence of malaria, researchers 
found that the local natives must travel 
several hours, even days, to get to a lab 
facility for malaria diagnosis via microscopy, 
the gold standard diagnosis method [1]. 
However, microscopy requires trained lab 
technicians, a reliable power supply, and 
materials for sample preparations [1]. Thus, 
some results are not available until four to 
six weeks later [1]. The delayed diagnosis 
further delays treatment and enables 




health centers with trained microscopists is 
limited or unavailable, diagnosis of malaria 
is often made based on clinical symptoms, 
but this method is at best 50% accurate 
giving false positives that waste medication 
and lead to drug-induced side effects [19].  
   Misdiagnosis leads to the improper use of 
anti-malarial drugs, which wastes treatment 
resources and can cause unexpected side 
effects [9]. On the other hand, untreated 
malaria leads to severe illness and eventual 
death. Countries with high prevalence of 
malaria suffer high economic losses – as 
much as a 1.3% decrease in gross domestic 
product (GDP) [18].  Therefore, there is a 
clear need for low-cost, portable, rapid 
diagnostic screening tools in developing 
countries, especially rural areas with 
logistical and financial constraints.   
 
Case study II. HIV 
 
Currently over 40 million people are 
infected with HIV with 96% living in 
developing countries [16]. Sub-Saharan 
Africa has the highest number of cases [16].  
In a study focused on the access to 
diagnostics in support of HIV/AIDS and 
tuberculosis treatment in developing 
countries, it was found that 90% of those 
living with HIV are unaware of their 
condition because they were never tested [3]. 
The large population of people living with 
HIV without their knowledge is a significant 
contributor to the transmission of HIV.  
Experienced lab technicians are 
limited in developing countries, thus 
effectively operating labs that can perform 
standard diagnostic tests are sparse. 
Furthermore, having a centralized health 
care center in developing countries is not 
practical when there are many rural 
communities with citizens that do not have 
access to transportation.  
While there are available low-cost 
and rapid HIV tests, these diagnostics are 
not being deployed [3]. Thus and method of 
deployment is necessary. The portable paper 
dispenser is one solution that could increase 
the deployment of diagnostic tests and 
enable global volunteers to administer more 
tests so that HIV patients are aware that they 
have the disease and prevent continued 
transmission.   
 
Case study III. Tuberculosis 
 
As much as one-third of the world’s 
population is estimated to have tuberculosis 
– mostly the latent form [3]. 15 million 
currently live with an active form of TB 
with 9 million new cases per year [3]. New 
cases of TB have risen in recent years due to 
HIV. TB causes 2 million deaths per year 
[3]. 
Despite the prevalence of TB, most 
of the developing countries are relying on 
115 year old acid-fast bacillus sputum smear 
tests [3]. Sensitivity is poor to begin with 
and it is even more difficult to accurately 
diagnose patients with HIV raising false 
negative results [3].    
Other limitations of sputum smears 




children and that analysis requires 
microscopes and trained lab technicians [3]. 
Thus current diagnostic tests used to detect 
TB are not only poor in accuracy but limited 
in mobility. A low-cost portable paper test is 




Considerations and parameters 
 
Developing countries are in great 
need of simple, portable, and effective 
infectious disease diagnostic devices that are 
cost effective. In 2009 the Gates Foundation 
announced a project to develop a standard 
platform for point-of-care diagnostic devices 
for the developing world because of 
concerns that less than 5% of deaths in 
developed nations are resulted from 
infectious disease whereas over 50% of 
deaths in many of the poorest regions are a 
result of infectious disease [8].  
While most diagnostic tools are 
idiosyncratic, new initiatives are calling for 
open source standardized diagnostic tools 
that many companies can develop particular 
equipment and parts for. The Gates 
Foundation has committed to offering $30 
million in grants to developing such devices 
with the goal being easy-to-use devices that 
will not require advanced training or 
supplies [8]. One device being developed is 
a shoe-box-sized reader that analyzes 
samples such as blood, saliva or urine 
submitted on a microfluidic card [8]. 
Another device is being developed by Paul 
Yager, a bioengineering professor at the 
University of Washington. His device is 
nicknamed the DxBox and has the 
multifunction of performing polymerase 
chain reaction. 
Given the great need for diagnostic 
tools that are suited for developing countries, 
the WHO has an established set of 
guidelines, ASSURED, to consider for new 
inventions: (i) affordable, (ii) sensitive, (iii) 
specific, (iv) user-friendly, (v) rapid and 
robust, (vi) equipment-free, and (vii) 
delivery to those who need it [11].  
 
Deployment and mobility need 
 
The important realization that 
transportation and accessibility to health 
care centers are limited in most developing 
countries has driven research towards the 
development of point-of-care (POC) 
diagnostics, which allows for convenient 
diagnosis on-site at the patient’s location. 
The attractive characteristics of POC 
technology are concepts that can be 
implemented to create successful diagnostic 
tests for third world countries: disposability, 
cost-effectiveness, ease of use and 
portability [5].  
To reduce the cost of diagnostics the 
following cost-effective measures can be 
implemented: minimal use of expensive 
reagents, inexpensive manufacturing for 
mass production, quality control, and 
miniaturization [13]. Other parameters that 
must be accounted for in devices for 
developing countries include streamlining 
the steps of use (i.e. eliminating menial 
intermediate steps such as cutting paper 
strips or washing processes) and 
environmental conditions, which broadly 
encompasses sensitivity to high 
temperatures, humidity, and inadequate 
water and electricity access [2].      
Infectious diseases are a challenging 
health issue globally, particularly for 
developing countries with limited resources 
and environmental barriers to overcome. 
Countless studies have identified the 
specific need for improvement in the 
diagnosis of infectious diseases. Better 
diagnostic devices would improve the 
diagnosis of major diseases such as malaria, 
tuberculosis, and HIV. Faster and more 




millions of lives and allow for better 
treatment and prevention while reducing the 
number of misdiagnosis. The Gates 
Foundation lists a syphilis detection 
diagnosis medical device as a tool that has 
the potential to prevent 215,000 stillbirths, 
and a standardized malaria test can save 
more than 2 million lives and prevent 450 
million unnecessary treatments due to 




 The identified public health problem 
is the need for accurate, low-cost, accessible 
diagnostic tests for infectious diseases – 
namely malaria, HIV, and tuberculosis. 
While these tests do exist particularly with 
the development of paper-based diagnostics, 
an easy method of transport and use of the 
tests is needed to conveniently utilize the 
diagnostic tests. The next step is 
commercialization and dissemination.  
 The portable paper diagnostic test 
dispenser is designed to be compatible with 
the Whitesides paper design. Whitesides has 
co-founded a nonprofit organization 
Diagnostics for All (DFA) for 
commercialization purposes. DFA plans to 
deploy the first tests to sub-Sahara Africa in 
the fall of 2010. The first tests will test for 
liver toxicity.  
 
Stage I. Low-cost paper diagnostic test 
 
  The first step in the overall process is 
to create an ASSURED diagnostic device 
that meets the additional design 
considerations such as disposability and low 
cost. Paper diagnostic tests are an ideal 
solution because expensive sensors and 
analyzers, external pumps, and power 
sources are eliminated. Paper diagnostics 
relies on the paper’s natural capillary action 
of liquid absorption and the inherent 
channels in patterned paper, which make 
paper an ideal medium for chemical 
reactions.   
Diagnostic tests made out of paper 
are a low cost solution that meets the 
ASSURED criteria.  Paper has various 
advantages over its plastic and glass 
counterparts and has been the recent focus 
of various researchers including Dr. George 
Whitesides of Harvard University. The 
following advantages of paper tests were 
listed in a recent paper published by 
members of the Whitesides Lab, who used 
Whatman No. 1 chromatography paper: thin 
(0.07 – 1 mm), lightweight (~10 mg/cm
2
), 
easy packaging and transport, compatible 
with biological samples, good medium for 
colorimetric tests, disposable by incineration, 
flexible and compatible with various 
printing technologies for simple fabrication, 
low cost and easily modified chemically 
[12]. Furthermore, these tests eliminate 
sharps waste, which is ideal for developing 
countries and significantly simplifies a 
relatively untrained health care volunteer’s 
task [17]. Needle disposal concerns are 
eliminated because the paper tests require 
only very small amounts of fluid.  
The current paper diagnostic tests 
developed have shown efficiency in that 
multiple tests can be performed on the same 
small 2 cm x 2 cm square as shown in Fig. 4. 
Rapid results appear ranging from 5 – 30 
minutes depending on the specific test. 




newspaper print technology drives down the 
cost of this device to $0.03 - $0.05 making 
paper diagnostics a realizable tool for 
detecting infectious diseases in developing 
countries [6]. 
c 
Stage II. Packaging and deployment 
  
 Now that cost effective paper 
diagnostic tools have been developed, there 
is a need for an efficient vehicle with which 
to package, transport, and deliver the tests to 
the populations in need. The proposed 
solution is a paper diagnostic dispenser 
based upon the simple tape dispenser 
concept with a few minor alterations: (i) 
casing will completely enclose internal 
wheel and test strips except for the one 
being dispensed, (ii) ratchet mechanism to 
allow for an exact dispense length, (iii) color 
code will be printed on the casing surface 
for easy reference. 
 
Detailed design schematics 
 
 The final built prototype consists of 
3 separate pieces: top and bottom casing 
shells and a freely-rotating spool. Additional 
added components include a spring and nail 





Stage III. Telemedicine  
 
The final components of the system 
involve diagnosis and treatment. With the 
portable paper dispenser and the rapid 
results given by paper tests developed by the 
Whitesides Group, it is possible for medical 
volunteers to travel to remote locations, 
administer diagnostic tests, and give a 
general on-spot diagnosis with the color 
code printed on the dispenser casing. This 
will be useful in providing information 
quickly, but the treatment does not stop 
there. The results of the paper diagnostic 
need to be sent to a central lab where trained 
health care workers can analyze the 
information and prescribe a specific 
diagnosis and treatment.  
 Telemedicine is a viable solution in 
remote settings. Mobile volunteers should be 
equipped with a camera phone. Following 
the appearance of results on paper tests, the 
worker will proceed to take a picture of the 
test and transmit the information to a central 
lab. This approach is efficient and allows for 
developing countries to access experts who 
under normal circumstances may not have 
the time to travel to distant or remote 




 The portable dispenses achieves 
several of the initial design goals. The tape 
analogy allows for the diagnostic tests to be 
efficiently packaged in the designed casing. 
The dispensing mechanism of the first 
prototype consistently allots 9cm per pull. 
The prototype consists of three separate 
parts: top and bottom casing and a free-
rotating spool. The hook spring allows for 
consistent test dispense and the nail is an 
attachment peg for the spring. The teeth In 
consideration of mass production, this 
device will ultimately be extremely low-cost. 
Based on comparable everyday plastic tape 
dispensers, an estimate of the portable 
diagnostic dispenser cost is somewhere 
under $0.50 to produce with the spring 




 The portable dispenser has 
undergone durability testing. The device has 
been found to have structural integrity 
surviving multiple drops onto a hard 
linoleum surface as well as 200N of exerted 
force pressing the case as well as pulling the 
tape.   
 The Whitesides Group has tested the 
paper diagnostics and the results of the 





Future testing will be conducted. The 
first deployment of the paper diagnostic tests 
is expected to occur in the fall of 2010. 
Liver toxicity tests will be used in sub-
Sahara Africa where much of the population 
is inflicted with HIV. HIV treatment drugs 
have harsh side effects especially to the liver 




allow for a better analysis of environmental 
impact on the tests.  
Following a conversation with a 
graduate student in Dr. Jeff Wang’s lab, one 
future direction that should be explored is to 
create a color patch for the diagnostic tests 
and a color correction program that can 
properly calibrate the colors for greater 
accuracy when interpreting results. The 
inventors of the paper diagnostic test also 
recognize the distortion of color images 
transmitted that could arise due to variable 
intensity based on lighting conditions, 
resolution of camera and focus of picture 
[12]. Printing a color patch onto the paper 
test that could be read by a program is one 
potential solution that can account for the 
variable conditions.  
 Another project direction would be 
to create a device to hold and dispose paper 
tests after they have been administered. The 
portable paper dispenser is a method for 
transporting new diagnostic tests, but after 
samples have been collected there is a need 
for a container to hold the paper tests for 
later disposal. There is also further work to 
be done to create more advanced paper tests 
that can diagnose infectious diseases such as 
HIV with greater accuracy.      
  
As Whitesides said himself at the 2010 TED 
conference, “a health care worker of the 
future is not a doctor, but an 18 year-old 
otherwise unemployed who has two things: 
a backpack full of these tests and a lancet to 
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Fig.10: Two-spool ratchet mechanism. 
Fig. 11: Ratchet wheel spool design. 
